ACHV:Achieve Life Science Inc - Stock Price Quote and Dividend Data
LATEST CLOSE STOCK PRICE
$0.88
EXCHANGE
NASDAQ
SECTOR
Health Care
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend Paid1970
52-Week Low/High Stock Price$0.83 - $4.63
Percent Held by Institutions13.13%
Revenue$0
Net Income$-20,511,000
Cash Flow$-3,072,000
EPS-0.45%
Market Cap$7,350,640
PE Ratio to Industry46%
Debt-Equity Ratio5.00%
Debt-Equity to Industry1.33%
Total Return Last 12 Months-40.54%
Total Return Last 3 Years-98.43%
Total Return Last 5 Years-99.64%
Latest Trade DateDec. 10, 2019
No Data available for Payment History.
Achieve Life Sciences is a clinical-stage pharmaceutical company engaged in the development and commercialization of cytisinicline for smoking cessation. Co.'s product candidate, Ccytisinicline is a smoking cessation aid that interacts with nicotine receptors in the brain by reducing the severity of nicotine withdrawal symptoms and the reward and satisfaction associated with smoking. Co. has a license and supply agreement with Sopharma, AD (Sopharma) for the development and commercialization of cytisinicline outside of Sopharma's territory, which consists of certain countries in Central and Eastern Europe, Scandinavia, North Africa, the Middle East and Central Asia, as well as Vietnam.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dec. 11, 2019CLOSE PRICE DECREASE: Achieve Life Science Inc (NASDAQ: ACHV) on 12-11-2019 decreased close price > 10% from $1.04 to $0.88
Read more...Dec. 10, 2019CLOSE PRICE INCREASE: Achieve Life Science Inc (NASDAQ: ACHV) on 12-10-2019 increased close price > 10% from $0.91 to $1.04
Read more...Nov. 21, 2019CLOSE PRICE INCREASE: Achieve Life Science Inc (NASDAQ: ACHV) on 11-21-2019 increased close price > 10% from $0.85 to $0.95
Read more...Dec. 11, 2019CLOSE PRICE DECREASE: AXM Pharma Inc (OTCBB: AXMP) on 12-11-2019 decreased close price > 10% from $0.00 to $0.00
Read more...Dec. 11, 2019CLOSE PRICE INCREASE: Aryx Therapeutics Inc (OTCBB: ARYX) on 12-11-2019 increased close price > 10% from $0.00 to $0.00
Read more...Dec. 11, 2019CLOSE PRICE DECREASE: Bio-Matrix Scientific Group Inc (OTCBB: BMSN) on 12-11-2019 decreased close price > 10% from $0.00 to $0.00
Read more...